262 related articles for article (PubMed ID: 37891632)
1. "That's why we're speaking up today": exploring barriers to overdose fatality prevention in Indianapolis' Black community with semi-structured interviews.
Seo DC; Satterfield N; Alba-Lopez L; Lee SH; Crabtree C; Cochran N
Harm Reduct J; 2023 Oct; 20(1):159. PubMed ID: 37891632
[TBL] [Abstract][Full Text] [Related]
2. 'It's the same thing as giving them CPR training': rural first responders' perspectives on naloxone.
Filteau MR; Green B; Kim F; McBride KA
Harm Reduct J; 2022 Oct; 19(1):111. PubMed ID: 36192736
[TBL] [Abstract][Full Text] [Related]
3. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island.
Nolen S; Zang X; Chatterjee A; Behrends CN; Green TC; Kumar A; Linas BP; Morgan JR; Murphy SM; Walley AY; Yan S; Schackman BR; Marshall BDL
Addiction; 2022 May; 117(5):1372-1381. PubMed ID: 34825427
[TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators of naloxone and safe injection facility interventions to reduce opioid drug-related deaths: A qualitative analysis.
Miller NM; Campbell C; Shorter GW
Int J Drug Policy; 2023 Jul; 117():104049. PubMed ID: 37247475
[TBL] [Abstract][Full Text] [Related]
5. A qualitative examination of naloxone access in three states: Connecticut, Kentucky, and Wisconsin.
Spector AL; Galletly CL; Christenson EA; Montaque HDG; Dickson-Gomez J
BMC Public Health; 2022 Jul; 22(1):1387. PubMed ID: 35854278
[TBL] [Abstract][Full Text] [Related]
6. Naloxone administration by law enforcement officers in New York State (2015-2020).
Pourtaher E; Payne ER; Fera N; Rowe K; Leung SJ; Stancliff S; Hammer M; Vinehout J; Dailey MW
Harm Reduct J; 2022 Sep; 19(1):102. PubMed ID: 36123614
[TBL] [Abstract][Full Text] [Related]
7. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.
Parkin S; Neale J; Brown C; Jones JD; Brandt L; Castillo F; Campbell ANC; Strang J; Comer SD
Int J Drug Policy; 2021 Jan; 87():102968. PubMed ID: 33096365
[TBL] [Abstract][Full Text] [Related]
8. An exploratory study of a hands-on naloxone training for rural clinicians and staff.
Cody SL; Hines CB; Glenn CJ; Sharp-Marbury R; Newman S
J Nurs Scholarsh; 2023 May; 55(3):599-604. PubMed ID: 36411494
[TBL] [Abstract][Full Text] [Related]
9. If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study.
Slocum S; Ozga JE; Joyce R; Walley AY; Pollini RA
BMC Public Health; 2022 Apr; 22(1):735. PubMed ID: 35418048
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.
Sajwani HS; Williams AV
Harm Reduct J; 2022 Oct; 19(1):117. PubMed ID: 36266701
[TBL] [Abstract][Full Text] [Related]
11. Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high-strength opioids for chronic non-cancer pain: An explorative intervention development study.
Mercer F; Parkes T; Foster R; Steven D; McAuley A; Baldacchino A; Steele W; Schofield J; Matheson C
Drug Alcohol Rev; 2023 Mar; 42(3):517-526. PubMed ID: 36165733
[TBL] [Abstract][Full Text] [Related]
12. Naloxone analogy and opioid overdose terminology preferences among rural caregivers: Differences by race.
Hosea K; Mashburn P; Kennelty K; Westrick SC; Look K; Evon D; Carpenter DM
J Am Pharm Assoc (2003); 2023; 63(5):1521-1529.e3. PubMed ID: 37149142
[TBL] [Abstract][Full Text] [Related]
13. Legacies of the war on drugs: Next of kin of persons who died of opioid overdose and harm reduction interventions in Philadelphia.
Uzwiak BA; Hudgins A; Pizzicato LN
Int J Drug Policy; 2021 Nov; 97():103351. PubMed ID: 34252788
[TBL] [Abstract][Full Text] [Related]
14. Considerations for the design of overdose education and naloxone distribution interventions: results of a multi-stakeholder workshop.
Sellen K; Markowitz B; Parsons JA; Leece P; Handford C; Goso N; Hopkins S; Klaiman M; Shahin R; Milos G; Wright A; Charles M; Morrison L; Strike C; Orkin A;
BMC Public Health; 2023 May; 23(1):888. PubMed ID: 37189052
[TBL] [Abstract][Full Text] [Related]
15. Overdose responses among rural people who use drugs: A multi-regional qualitative study.
Baker R; Fredericksen RJ; Rudolph AE; Stopka TJ; Walters SM; Fadanelli M; Bolinski RS; Sibley AL; Stack E; Crane HM; Korthuis PT; Seal DW
Harm Reduct J; 2024 May; 21(1):107. PubMed ID: 38822387
[TBL] [Abstract][Full Text] [Related]
16. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
[TBL] [Abstract][Full Text] [Related]
18. Opioid Overdoses and Take-Home Naloxone Interventions: Ethnographic Evidence for Individual-Level Barriers to Treatment of Opioid Use Disorders in Rural Appalachia.
Garcia V; McCann L; Lauber E; Vaccaro C; Swauger M; Heckert DA
Subst Use Misuse; 2024; 59(9):1313-1322. PubMed ID: 38635977
[No Abstract] [Full Text] [Related]
19. Factors associated with gaps in naloxone knowledge: evidence from a 2022 great plains survey.
Cooper-Ohm S; Habecker P; Humeniuk R; Bevins RA
Harm Reduct J; 2024 Feb; 21(1):37. PubMed ID: 38336722
[TBL] [Abstract][Full Text] [Related]
20. "They're not doing enough.": women's experiences with opioids and naloxone in Toronto.
Macleod ER; Tajbakhsh I; Hamilton-Wright S; Laliberte N; Wiese JL; Matheson FI
Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):26. PubMed ID: 33743756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]